Coagusense/coagsense waived PT/INR

We use Roche Coaguchek

Sent via Groubile.

We recently switched from Roche Coaguchek XS/XS+ to CoagSense.

Are you happy with the switch? How are results correlating with your core lab?

Hello, i currently have the Roche CoaguChek for our ACS clinics.  There correlated well when the Lab had ACL Top analyzers.  The Lab switched to Stago and now there is no correlation due to the different thromboplastins, ISI's etc.  How well does the Coag-Sense correlate? How easy is it to operate?  Any pros/cons for switching to it?

I wouldn't have considered it in the past, since it had no connectivity. However, they've recently put out a new version that is much smaller and does interface. I've looked over the documentation, and it looks good, but the proof is in the pudding! The device is cheaper than the Coaguchek. We did have Stago analyzers and it was not fun trying to correlate with our Coaguchek! My advice would be to contact a rep and get a demo, try it out for yourself.

We have performed correlations on the CoagSense having been dissatisfied with the Coaguchek XS correlations at INR >3.5. The biggest hurdle is getting user competency with the pipette while dosing the CoagSense strip. Once that is mastered, the correlations are much better at INR >3.5. Our results correlated better in the upper ranges with the CoagSense.

Sent via Groupsite Mobile.

I have a webinar meeting with CoagSense today.  I have a lot of technical questions for them!

For those using Coagusense, how are you documenting results in your EHR? The new device is out that will connect to an interface but RALS states they will not be able to connect till later on in the year.

Sent via Groupsite Mobile.

I reviewed the CoaguSense white paper.  The study claims on Stago they used Dade Innovin reagent.  To my knowledge, Stago is not an open system and only uses Neoplastin (hence the issue with correlations to the CoaguChek meter).  I have sent this to Stago for clarification because either a) we will need to retool our Stago analyzers at 5 hospitals to a human sourced thromboplastin or b) we will need to look into the feasibility of replacing 31 meters in out ACS clinics.  The Coagu/Sense rep said the study is correct, although the one they did at LeHigh Valley PA they pitched to me the Stago used Neoplastin.  The plot thickens.  I had looked at the CoaguSense a year ago for a solution to the Lab/POCT disparity but the lack of interface capability and the larger bulkier model would not have worked for our workflow.

Lehigh Valley Hospital_NEW Post Recall Roche Strips_v Coag-Sense-4-1.pdf Coag-Sense PT_INR System White Paper.pdf